An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma
Hutchmed
Hutchmed
UNC Lineberger Comprehensive Cancer Center
Baylor College of Medicine
Stanford University
Eisai Inc.
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Fred Hutchinson Cancer Center
Columbia University
Baylor College of Medicine
Fred Hutchinson Cancer Center
Celgene
Massachusetts General Hospital
Amgen
Ohio State University Comprehensive Cancer Center